Adobe: GenAI Is Improving Sales, But Not Fast Enough

Summary:

  • Adobe has been able to rapidly embed Gen AI features into its products, which are getting a lot of traction.
  • It has also been able to generate more sales but these are progressing gradually, as it reshapes its product portfolio in a market that has been disrupted.
  • Adobe’s inability to hike pricing hints that the competition is strong while it has lost the first-mover advantage in image creation.
  • Due to high investor expectations built into the stock price, it could suffer from further volatility.
  • Also, as AI-driven image generation takes center stage, Microsoft, with its investment in OpenAI is now a competitor, in addition to being a partner.

Adobe Home

mvp64/E+ via Getty Images

I last covered Adobe (NASDAQ:ADBE) in September 2022, two months before the launch of OpenAI’s ChatGPT. I had a hold position mainly based on its $20 billion bid to acquire Figma. Eventually, the deal did not materialize, and the


Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

This is an investment thesis and is intended for informational purposes. Investors are kindly requested to do additional research before investing.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.


Leave a Reply

Your email address will not be published. Required fields are marked *